FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 38

Author

Admin 422 posts 0 comments

Whitepaper

Cards and Payments: Delivering the Digital Opportunity

Admin Aug 29, 2024
New technology has always presented card issuers, whether they are banks or retailers, with challenges and…
Whitepaper

Future of Banking Industry

Admin Aug 28, 2024
There may not be many striking features in this scenario, but let’s see what processes are running behind the…
Featured News

Future-Focused Finance – Active Listening and Powerful Questioning

Admin Aug 27, 2024
Future-Focused Finance, through its Great Place to Work action area, aims to enable individuals and teams to…
Infographics

FINANCIAL INSTITUTIONS REQUIRE FUTURE-READY PHYSICAL SECURITY

Admin Aug 26, 2024
The convergence of technological innovation, new regulations, and security risks is driving rapid change in the…
Whitepaper

Best Practices in Social Listening Financial Services And Insurance

Admin Aug 22, 2024
Whether you’re obtaining new clients or recruiting talent, the Financial Services space is incredibly competitive.…
Whitepaper

Shifting focus Risk culture is at the forefront of banking

Admin Aug 21, 2024
The new message this year is the almost universal focus on risk culture, with an emphasis on conduct, reflecting…
Whitepaper

SIMPLIFY TRADE FINANCE OPERATIONS WITH INTELLIGENT AUTOMATION

Admin Aug 19, 2024
Intelligent Automation (IA) facilitates Trade Finance Operations. The IA solution engages cutting edge…
Whitepaper

The Modernization of Payments and the New Bank Tech Company

Admin Aug 14, 2024
The writing is on the wall. Disruptive technologies, evolving consumer behaviors and expectations, innovative new…
Uncategorized

Innovation is Crucial to the Success of Finance & Accounting

Admin Aug 13, 2024
Companies can innovate in any number of ways. They can design new products, embark on new market strategies,…
Whitepaper

To Buy or to Build: Which is the Best Path for Digital Transformation?

Admin Aug 12, 2024
Modern, cloud-based digital technology is necessary for financial institutions that are seeking to address the…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Understanding Credit Card Losses: Causes, Prevention, and Recovery
    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future

    ARTICLE

    BioSyent Declares Second Quarter 2026 Dividend
    2026-05-14T22:01:00Z
    MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend...


    Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
    2026-05-14T22:00:29Z
    The report, led by the United Kingdom’s APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate...


    BioSyent Releases Financial Results for First Quarter 2026
    2026-05-14T22:00:00Z
    MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2026. Key highlights...


    Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-05-14T21:27:07Z
    Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring (CBGM) technology


    LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
    2026-05-14T21:18:00Z
    BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer...


    Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T21:15:00Z
    Aurix Product Exhibiting Strong Market Growth


    NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum
    2026-05-14T21:00:57Z
    TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical...


    Precipio Announces Q1 2026 Financial Results
    2026-05-14T21:00:00Z
    Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth


    HEALIOS K.K. to Present at Jefferies Global Healthcare Conference
    2026-05-14T20:30:00Z
    NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Jefferies Global Healthcare Conference in...


    Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
    2026-05-14T20:30:00Z
    TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three...


    Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-14T20:30:00Z
    Company Advances SkinJect® and Teverelix® Clinical Programs While Strengthening Financing Flexibility and Expanding Strategic Development Initiatives


    Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
    2026-05-14T20:30:00Z
    Includes Full Exercise of $15.0 million Over-Allotment Option


    HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
    2026-05-14T20:25:00Z
    MIRAMAR, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat...


    Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
    2026-05-14T20:20:00Z
    Phase 1b Registrational Clinical Study of SER-252 Underway in Advanced Parkinson’s Disease; TFL data from the SAD study arm targeted for first half of 2027 -


    Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T20:15:00Z
    Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma (rrMM)


    First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T20:15:00Z
    SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory...


    BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    2026-05-14T20:15:00Z
    KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire...


    Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update
    2026-05-14T20:10:00Z
    Completed successful End-of-Phase 2 meeting with the FDA and selected onvansertib dose and chemotherapy regimen for planned Phase 3 trial


    Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights
    2026-05-14T20:10:00Z
    SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today reported...


    Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-05-14T20:10:00Z
    ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $205...


    Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
    2026-05-14T20:07:28Z
    Moves designed to strengthen leadership and financial position, advance portfolio, and leverage expertise in precision immunoengineering


    Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
    2026-05-14T20:05:00Z
    ZUG, Switzerland, May 14, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2026 Annual General Meeting...


    Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
    2026-05-14T20:05:00Z
    ZUG, Switzerland, May 14, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2026 Annual General Meeting...


    AVITA Medical Reports First Quarter 2026 Financial Results
    2026-05-14T20:05:00Z
    VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”),...


    NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
    2026-05-14T20:05:00Z
    TORONTO, Ontario and HAIFA, Israel, May 14, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative...


    SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
    2026-05-14T20:05:00Z
    ALISO VIEJO, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today reported recent business highlights and financial results...


    ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
    2026-05-14T20:05:00Z
    PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health...


    Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
    2026-05-14T20:05:00Z
    – Late-breaking oral presentation of Phase 3 envudeucitinib data in moderate-to-severe plaque psoriasis (PsO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting demonstrating early and robust improvements in...


    Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
    2026-05-14T20:05:00Z
    – On track to report initial safety, PK and early activity from Phase 1 dose-escalation trial of STRO-004, potential best-in-class Tissue Factor ADC, in mid-2026 –


    Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
    2026-05-14T20:05:00Z
    VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel,...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.